[go: up one dir, main page]

WO2004058809A3 - Nouveaux polypeptides bacteriens essentiels - Google Patents

Nouveaux polypeptides bacteriens essentiels Download PDF

Info

Publication number
WO2004058809A3
WO2004058809A3 PCT/CA2003/001934 CA0301934W WO2004058809A3 WO 2004058809 A3 WO2004058809 A3 WO 2004058809A3 CA 0301934 W CA0301934 W CA 0301934W WO 2004058809 A3 WO2004058809 A3 WO 2004058809A3
Authority
WO
WIPO (PCT)
Prior art keywords
bacterial polypeptides
essential bacterial
novel essential
novel
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CA2003/001934
Other languages
English (en)
Other versions
WO2004058809A2 (fr
Inventor
Aled Edwards
Akil Dharamsi
Masoud Vedadi
Cheryl Arrowsmith
Cristina Virag
Dhushy Kanagarajah
Kamran Mansoury
Hui Ouyang
Simon Houston
Kristina Buzadzija
Megan Domagala
Ivy Ng
Rosanne Thalakada
Matthew Tai
Kathleen Nethery
Bryan Beattie
Dawn Richards
Veronica Canadien
Benjamin Pinder
Merry-Lynn Mcdonald
Muhammad Zahoor Alam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affinium Pharmaceuticals Inc
Original Assignee
Affinium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affinium Pharmaceuticals Inc filed Critical Affinium Pharmaceuticals Inc
Priority to AU2003287824A priority Critical patent/AU2003287824A1/en
Publication of WO2004058809A2 publication Critical patent/WO2004058809A2/fr
Publication of WO2004058809A3 publication Critical patent/WO2004058809A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des cibles polypeptides pour bactéries pathogènes. L'invention concerne également des caractéristiques biochimiques et biophysiques de ces polypeptides.
PCT/CA2003/001934 2002-12-26 2003-12-19 Nouveaux polypeptides bacteriens essentiels Ceased WO2004058809A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003287824A AU2003287824A1 (en) 2002-12-26 2003-12-19 Novel essential bacterial polypeptides

Applications Claiming Priority (28)

Application Number Priority Date Filing Date Title
US43656302P 2002-12-26 2002-12-26
US43655102P 2002-12-26 2002-12-26
US43658702P 2002-12-26 2002-12-26
US60/436,563 2002-12-26
US60/436,587 2002-12-26
US60/436,551 2002-12-26
US43698102P 2002-12-30 2002-12-30
US43716702P 2002-12-30 2002-12-30
US43700702P 2002-12-30 2002-12-30
US60/437,167 2002-12-30
US60/437,007 2002-12-30
US60/436,981 2002-12-30
US43727402P 2002-12-31 2002-12-31
US43761702P 2002-12-31 2002-12-31
US43755202P 2002-12-31 2002-12-31
US43746402P 2002-12-31 2002-12-31
US43754402P 2002-12-31 2002-12-31
US43761802P 2002-12-31 2002-12-31
US43753202P 2002-12-31 2002-12-31
US43764002P 2002-12-31 2002-12-31
US60/437,617 2002-12-31
US60/437,274 2002-12-31
US60/437,552 2002-12-31
US60/437,544 2002-12-31
US60/437,464 2002-12-31
US60/437,532 2002-12-31
US60/437,618 2002-12-31
US60/437,640 2002-12-31

Publications (2)

Publication Number Publication Date
WO2004058809A2 WO2004058809A2 (fr) 2004-07-15
WO2004058809A3 true WO2004058809A3 (fr) 2005-02-24

Family

ID=32686480

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2003/001934 Ceased WO2004058809A2 (fr) 2002-12-26 2003-12-19 Nouveaux polypeptides bacteriens essentiels

Country Status (2)

Country Link
AU (1) AU2003287824A1 (fr)
WO (1) WO2004058809A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007133153A1 (fr) 2006-05-16 2007-11-22 Dermagen Ab Peptides antimicrobiens améliorés

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ASOH S ET AL: "Nucleotide sequence of the pbpA gene and characteristics of the deduced amino acid sequence of penicillin-binding protein 2 of Escherichia coli K12.", EUROPEAN JOURNAL OF BIOCHEMISTRY / FEBS. 15 OCT 1986, vol. 160, no. 2, 15 October 1986 (1986-10-15), pages 231 - 238, XP009035325, ISSN: 0014-2956 *
DATABASE EMBL [online] 19 September 1987 (1987-09-19), XP002292596, retrieved from EBI Database accession no. X04516 *
DATABASE EMBL 1 November 1988 (1988-11-01), XP002292597, retrieved from EBI Database accession no. P05850 *
EDWARDS A M ET AL: "PROTEIN PRODUCTION: FEEDING THE CRYSTALLOGRAPHERS AND NMR SPECTROSCOPISTS", NATURE STRUCTURAL BIOLOGY, NEW YORK, NY, US, vol. 7, no. SUPPL, November 2000 (2000-11-01), pages 970 - 972, XP001154099, ISSN: 1072-8368 *

Also Published As

Publication number Publication date
AU2003287824A8 (en) 2004-07-22
AU2003287824A1 (en) 2004-07-22
WO2004058809A2 (fr) 2004-07-15

Similar Documents

Publication Publication Date Title
WO2004041854A3 (fr) Nouveaux polypeptides bacteriens essentiels
WO2003087353A3 (fr) Nouveaux polypeptides purifies impliques dans la biogenese membranaire
AU2002309650A1 (en) Highly conserved proteins from gram-positive bacteria
EP2434016A3 (fr) Expression de proteines mammifères dans Pseudomonas fluorescens
WO2006028561A3 (fr) Nouveaux polypeptides fabi purifies issus de fransicella tularensis
WO2007093848A3 (fr) Nouveaux polypeptides purifiés issus de helicobacter pylori
WO2003102190A3 (fr) Nouveaux polypeptides purifies responsables de la viabilite bacterienne
WO2004058809A3 (fr) Nouveaux polypeptides bacteriens essentiels
WO2003044185A3 (fr) Nouveaux polypeptides purifies iimpliques dans un metabolisme general
WO2004081206A3 (fr) Nouveaux polypeptides codes par des genes bacteriens essentiels
AU2003285485A1 (en) 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
WO2003083099A3 (fr) Nouveaux polypeptides purifies impliques dans la synthese et la modification des proteines
WO2003084987A3 (fr) Nouveaux polypeptides purifies intervenant dans la synthese et la transformation de l'acide nucleique
WO2003025008A3 (fr) Nouveaux polypeptides purifies impliques dans le traitement de proteines
WO2003025004A3 (fr) Polypeptides purifies intervenant dans le traitement d'acides nucleiques
WO2003027139A3 (fr) Nouveaux polypeptides purifiees impliques dans la biosynthese membranaire
WO2003087145A3 (fr) Nouveaux polypeptides purifies impliques dans la detection de densite cellulaire
WO2003084986A3 (fr) Nouveaux polypeptides modifies impliques dans le metabolisme cellulaire
WO2004044189A3 (fr) Nouveaux polypeptides purifies jouant un role dans le metabolisme
WO2003035858A3 (fr) Nouveaux polypeptides purifies impliques dans le traitement des acides nucleiques
WO2003025006A3 (fr) Nouveaux polypeptides purifies impliques dans le metabolisme des cofacteurs
WO2003025007A3 (fr) Nouveaux polypeptides purifies impliques dans la biosynthese membranaire
WO2003025005A3 (fr) Nouveaux polypeptides purifies impliques dans le traitement des proteines
WO2003085103A3 (fr) Nouveaux polypeptides purifies impliques dans l'hydrolyse de nucleotides
WO2004042043A3 (fr) Structures cristallines de 3-epimerases bacteriennes de ribulose-phosphate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11167924

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 11167924

Country of ref document: US